Results 261 to 270 of about 15,170 (273)
Some of the next articles are maybe not open access.

Abstract 2056: Click chemistry enabled selective activation of highly cytotoxic MMAE payload at tumors using TROP2 targeting agent

Cancer Research
Abstract Shasqi is advancing the Click Activated Protodrugs Against Cancer (CAPAC®) platform based on click chemistry, a Nobel Prize winning technology. The platform is modular and comprises 1) an activator that target specific antigens, and 2) inert cancer drugs, protodrugs, which are selectively activated at tumors via click chemistry.
George Coricor   +5 more
openaire   +1 more source

Antibody Drug Conjugates with a Novel Translation Inhibitor Payload Demonstrate Cytotoxicity and Tumor Growth Reduction in Multiple Myeloma Models

Blood
Background Antibody drug conjugates (ADCs) are a validated modality for the targeted delivery of cytotoxic payloads to myeloma cells while sparing healthy tissue. To achieve the full potential of ADCs in multiple myeloma patients, it will be important to have ADCs that incorporate payloads with ...
openaire   +1 more source

Quantitative bioanalysis of antibody-conjugated payload in monkey plasma using a hybrid immuno-capture LC–MS/MS approach: Assay development, validation, and a case study

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 2015
Huidong Gu   +2 more
exaly  

Affibody-mediated peptide nucleic acid pretargeting for delivery of cytotoxic payloads to HER2 positive carcinoma

Proceedings of the 37th European Peptide Symposium
Jacob Clinton   +2 more
openaire   +1 more source

Dual-payload antibody–drug conjugates: Taking a dual shot

European Journal of Medicinal Chemistry
Yuxi Wang
exaly  

Home - About - Disclaimer - Privacy